Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in AVTX held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 5.1M | $94.3M | +77.1% | 11.697% | 0.00% |
| 2 | BlackRock, Inc. | 4.4M | $80.7M | +1234.7% | 10.012% | 0.00% |
| 3 | Deep Track Capital, LP | 3.6M | $66.7M | — | 8.279% | 0.97% |
| 4 | Caligan Partners LP | 3.2M | $58.5M | +93.5% | 7.256% | 2.75% |
| 5 | TCG Crossover Management, LLC | 3.0M | $55.8M | +308.6% | 6.920% | 1.34% |
| 6 | Affinity Asset Advisors, LLC | 2.9M | $53.6M | +116.3% | 6.651% | 2.42% |
| 7 | STATE STREET CORP | 2.9M | $53.4M | +3932.3% | 6.627% | 0.00% |
| 8 | FARALLON CAPITAL MANAGEMENT, L.L.C. | 2.5M | $46.2M | +172.7% | 5.729% | 0.21% |
| 9 | Point72 Asset Management, L.P. | 2.4M | $44.1M | +160.5% | 5.475% | 0.05% |
| 10 | Avoro Capital Advisors LLC | 2.3M | $43.1M | +65.5% | 5.351% | 0.39% |
| 11 | VANGUARD CAPITAL MANAGEMENT LLC | 2.3M | $41.8M | +214.6% | 5.193% | 0.00% |
| 12 | BVF INC/IL | 2.1M | $38.4M | +27.1% | 4.760% | 0.98% |
| 13 | BANK OF AMERICA CORP /DE/ | 1.9M | $35.4M | +197.6% | 4.389% | 0.00% |
| 14 | Nantahala Capital Management, LLC | 1.9M | $34.4M | +50.8% | 4.271% | 0.57% |
| 15 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.7M | $32.0M | +102.5% | 3.965% | 0.04% |
| 16 | Soleus Capital Management, L.P. | 1.7M | $30.6M | +274.4% | 3.796% | 1.05% |
| 17 | BRAIDWELL LP | 1.6M | $30.1M | — | 3.737% | 1.11% |
| 18 | ALLIANCEBERNSTEIN L.P. | 1.3M | $23.3M | — | 2.891% | 0.01% |
| 19 | UBS Group AG | 1.2M | $22.3M | +5.9% | 2.773% | 0.00% |
| 20 | Logos Global Management LP | 1.1M | $21.3M | -11.5% | 2.637% | 0.91% |
| 21 | GEODE CAPITAL MANAGEMENT, LLC | 1.1M | $20.4M | +550.5% | 2.535% | 0.00% |
| 22 | Commodore Capital LP | 1.0M | $18.8M | +110.8% | 2.336% | 1.12% |
| 23 | RA CAPITAL MANAGEMENT, L.P. | 1.0M | $18.5M | +50.8% | 2.293% | 0.16% |
| 24 | GOLDMAN SACHS GROUP INC | 946K | $17.5M | +1474.4% | 2.170% | 0.00% |
| 25 | Trails Edge Capital Partners, LP | 892K | $16.5M | — | 2.046% | 2.62% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in AVTX — a direct measure of their conviction.
Filings activity in AVTX during Q2 2026, grouped by how each filer changed its position.
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 128 | +27% | 164.37% | +85.74 pp | $1.30B | +172% |
| Q1 2026 | 101 | +19% | 78.63% | +31.88 pp | $479M | +29% |
| Q4 2025 | 85 | +29% | 46.75% | +11.27 pp | $370M | +88% |
| Q3 2025 | 66 | +83% | 35.48% | +17.49 pp | $197M | +402% |
| Q2 2025 | 36 | +2.9% | 17.99% | 0.94 pp | $39M | 41% |
| Q1 2025 | 35 | +2.9% | 18.93% | +1.66 pp | $66M | +19% |
| Q4 2024 | 34 | +13% | 17.27% | +2.00 pp | $56M | 12% |
| Q3 2024 | 30 | — | 15.27% | — | $63M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying AVTX stock.
Based on Q2 2026 13F filings, institutional ownership of Avalo Therapeutics, Inc. stands at 164.4%, held across 128 reporting institutions.
FMR LLC is the largest reported institutional holder of AVTX, with approximately 5,100,216 shares worth $0.09B as of Q2 2026.
Yes — 1 widely-followed marquee investor appear among the top 25 institutional holders of AVTX, including Point72 Asset Management, L.P..
Our composite Smart Money Score for AVTX is 68 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
53 institutions opened new positions in AVTX during Q2 2026, while 26 fully exited. 57 added to existing positions and 17 trimmed.
AVTX institutional ownership rose by 85.74 percentage points quarter-over-quarter, with a net change of +27 holders.
The top 10 institutions account for 45.9% of all reported 13F value in AVTX, and the top 25 account for 76.7%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Avalo Therapeutics, Inc. (AVTX) Institutional Ownership